Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Valneva SE (VALN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.70-1.24 (-5.18%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Down

Gap Down

Previous Close23.94
Open22.78
Bid21.51 x 800
Ask31.23 x 800
Day's Range22.23 - 22.78
52 Week Range13.71 - 67.84
Volume23,444
Avg. Volume29,649
Market Cap1.222B
Beta (5Y Monthly)0.98
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for VALN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Valneva SE
    Analyst Report: Moderna IncModerna Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious and cardiovascular diseases, rare diseases, immunological conditions, and cancer. The company has approximately 2,700 employees.
    Rating
    Fair Value
    Economic Moat
    22 days agoArgus Research
View more
Advertisement
Advertisement